Kazumasa Shinozuka Selected Research

Kazumasa Shinozuka Research Topics

Disease

18	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 12/2004
11	Neoplasms (Cancer) 01/2015 - 01/2003
10	Melanoma (Melanoma, Malignant) 01/2019 - 02/2003
5	Carcinoma (Carcinomatosis) 01/2019 - 01/2006
4	Neoplasm Metastasis (Metastasis) 11/2013 - 01/2003
3	Overactive Urinary Bladder (Overactive Bladder) 12/2021 - 01/2019
3	Hypertension (High Blood Pressure) 09/2015 - 11/2010
3	Body Weight (Weight, Body) 07/2013 - 12/2002
3	Experimental Melanoma 12/2004 - 01/2003
2	Fatigue 01/2020 - 08/2019
2	Vascular Diseases (Vascular Disease) 04/2016 - 02/2006
2	Atherosclerosis 01/2014 - 07/2009
2	Fibrosarcoma 03/2009 - 06/2008
1	Dizziness (Lightheadedness) 02/2021
1	Headache (Headaches) 02/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Proteinuria 01/2021
1	Diarrhea 01/2020
1	Constipation 08/2019
1	Inflammation (Inflammations) 10/2014
1	Arteriosclerosis 01/2014
1	Hyperuricemia 01/2014
1	Hemorrhage 01/2012
1	Insulin Resistance 05/2011
1	Morbid Obesity 11/2010

Drug/Important Bio-Agent (IBA)

9	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2017 - 02/2006
7	cordycepinIBA 01/2015 - 12/2004
5	PAR-2 ReceptorIBA 01/2021 - 10/2014
3	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 12/2021 - 01/2020
3	SmokeIBA 01/2019 - 07/2009
3	Ginkgo biloba extract (Rokan)IBA 01/2012 - 04/2002
3	Protein Kinase CIBA 05/2008 - 02/2003
2	EnzymesIBA 01/2021 - 12/2002
2	Nicotine FDA Link 01/2019 - 07/2009
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019 - 01/2010
2	SaltsIBA 09/2015 - 01/2007
2	ApolipoproteinsIBA 01/2014 - 07/2009
2	CalciumIBA 02/2013 - 06/2008
2	Telmisartan (Micardis)FDA Link 02/2013 - 05/2011
2	Glucose (Dextrose)FDA LinkGeneric 05/2011 - 11/2010
2	Adenosine Triphosphate (ATP)IBA 03/2009 - 06/2008
2	Adenosine A3 ReceptorIBA 06/2008 - 01/2006
2	midostaurinIBA 03/2003 - 02/2003
1	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2021
1	N- (4- ((5- (hydroxy(phenyl)methyl)pyrrolidin- 2- yl)methyl)phenyl)- 4- oxo- 4,6,7,8- tetrahydropyrrolo(1,2- a)pyrimidine- 6- carboxamideIBA 12/2021
1	BenzodiazepinesIBA 02/2021
1	Hypnotics and Sedatives (Sedatives)IBA 02/2021
1	Muscarinic AntagonistsIBA 01/2021
1	mirabegronIBA 01/2021
1	Vasodilator Agents (Vasodilators)IBA 01/2021
1	Sodium-Glucose Transport ProteinsIBA 01/2021
1	Charcoal (Charbon)IBA 01/2020
1	Siberian ginseng rootIBA 01/2020
1	Carbachol (Carbastat)FDA Link 01/2020
1	Angiotensin II Type 1 Receptor BlockersIBA 10/2019
1	azilsartanIBA 10/2019
1	Loperamide (Imodium)FDA LinkGeneric 08/2019
1	royal jellyIBA 08/2019
1	2-butenal (crotonaldehyde)IBA 01/2019
1	Acrolein (Aqualin)IBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Furaldehyde (Furfural)IBA 01/2019
1	3-buten-2-one (methyl vinyl ketone)IBA 01/2019
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2019
1	ApelinIBA 12/2018
1	Cysteine (L-Cysteine)FDA Link 12/2018
1	2-furoyl-LIGRLO-amideIBA 04/2017
1	Cyclic GMPIBA 04/2017
1	SaponinsIBA 04/2016
1	AdipokinesIBA 01/2016
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2015
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2015
1	Matrix Metalloproteinases (MMPs)IBA 01/2015
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2015
1	Peptide Hydrolases (Proteases)FDA Link 10/2014
1	Uric Acid (Urate)IBA 01/2014
1	Apolipoproteins E (ApoE)IBA 01/2014
1	Allopurinol (Remid)FDA LinkGeneric 01/2014
1	Therapeutic UsesIBA 01/2014
1	BenzbromaroneIBA 01/2014
1	Alanine Transaminase (SGPT)IBA 11/2013
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 07/2013
1	Acetylcholine (Acetylcholine Chloride)FDA Link 07/2013
1	tempolIBA 07/2013
1	Proteins (Proteins, Gene)FDA Link 02/2013
1	Warfarin (Coumadin)FDA LinkGeneric 01/2012
1	Serum AlbuminIBA 09/2011
1	CholesterolIBA 05/2011
1	Triglycerides (Triacylglycerol)IBA 05/2011
1	sesaminIBA 01/2010
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2010
1	Taurine FDA Link 01/2010
1	CurcuminIBA 01/2010
1	Capsaicin (Zostrix)FDA Link 01/2010
1	GenisteinIBA 01/2010

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2019
2	Drug Therapy (Chemotherapy) 12/2021 - 01/2003
1	Oral Administration 08/2019
1	Protein-Restricted Diet (Diet, Protein Restricted) 09/2011